FI54120C - FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO - Google Patents

FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO

Info

Publication number
FI54120C
FI54120C FI45/72A FI4572A FI54120C FI 54120 C FI54120 C FI 54120C FI 45/72 A FI45/72 A FI 45/72A FI 4572 A FI4572 A FI 4572A FI 54120 C FI54120 C FI 54120C
Authority
FI
Finland
Prior art keywords
indol
dihydroimidaso
anvaidbara
antidepressivt
verkande
Prior art date
Application number
FI45/72A
Other languages
Finnish (fi)
Other versions
FI54120B (en
Inventor
Alan Chapman White
Robin Michael Black
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of FI54120B publication Critical patent/FI54120B/en
Application granted granted Critical
Publication of FI54120C publication Critical patent/FI54120C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
FI45/72A 1971-01-11 1972-01-10 FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO FI54120C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (2)

Publication Number Publication Date
FI54120B FI54120B (en) 1978-06-30
FI54120C true FI54120C (en) 1978-10-10

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
FI45/72A FI54120C (en) 1971-01-11 1972-01-10 FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO

Country Status (20)

Country Link
JP (1) JPS5531156B2 (en)
AR (1) AR192734A1 (en)
AT (1) AT312595B (en)
AU (1) AU464388B2 (en)
BE (1) BE777911A (en)
CA (1) CA1012150A (en)
CH (1) CH573938A5 (en)
CY (1) CY926A (en)
DK (1) DK150143C (en)
EG (1) EG10888A (en)
ES (2) ES398678A1 (en)
FI (1) FI54120C (en)
FR (1) FR2121699B1 (en)
GB (1) GB1366133A (en)
HK (1) HK52877A (en)
IE (1) IE35956B1 (en)
KE (1) KE2777A (en)
MY (1) MY7800048A (en)
NL (1) NL174251C (en)
SE (1) SE398645B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (en) * 1977-06-06 1983-10-12 株式会社日立製作所 information retrieval device
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (en) * 1984-03-28 1985-10-15 Casio Comput Co Ltd Small-sized electronic apparatus with data storage function
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
SE398645B (en) 1978-01-09
FI54120B (en) 1978-06-30
AU3755872A (en) 1973-07-05
JPS4839500A (en) 1973-06-09
GB1366133A (en) 1974-09-11
CH573938A5 (en) 1976-03-31
HK52877A (en) 1977-10-20
FR2121699B1 (en) 1975-08-01
AR192734A1 (en) 1973-03-14
MY7800048A (en) 1978-12-31
DK150143C (en) 1987-06-01
EG10888A (en) 1978-06-30
ES409296A1 (en) 1976-03-16
IE35956B1 (en) 1976-07-07
KE2777A (en) 1977-10-21
CA1012150A (en) 1977-06-14
CY926A (en) 1977-12-23
NL7200415A (en) 1972-07-13
NL174251C (en) 1984-05-16
IE35956L (en) 1972-07-11
FR2121699A1 (en) 1972-08-25
NL174251B (en) 1983-12-16
BE777911A (en) 1972-07-11
AU464388B2 (en) 1975-08-28
JPS5531156B2 (en) 1980-08-15
AT312595B (en) 1974-01-10
DK150143B (en) 1986-12-15
ES398678A1 (en) 1975-05-16

Similar Documents

Publication Publication Date Title
SE402592B (en) PROCEDURE FOR THE PREPARATION OF 2-ALKYL-3-ACYL-PYRAZOLO (1,5-A) PYRIDINES
IL39988A0 (en) Pyrazolopyrimidines and pharmaceutical compositions containing them
SE428210B (en) TRIAZOLO DERIVATIVES FOR COMBATING VEXTPATOGENO ORGANISMS
CA952259A (en) Foldable bed structure
ZA721805B (en) Platform structure
SE389499B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF TRIAZOLO (4,3-A) (1,4) BENSODIAZEPIN DERIVATIVES
FI54121C (en) PROCEDURE FOR THE FRAMSTATION OF THE BLODTRYCKSSAENKANDE IMIDAZO- (1,2-A) -IMIDAZOLER-PYRIMIDINER OCH DIAZEPINER OCH DERAS SYRAADDITIONSSALTER
SE396388B (en) ANALOGICAL PREPARATION FOR THE PREPARATION OF 2,3-DIHYDRO-OXO-IMIDAZO- / 1,2-A / PYRIMIDINES
FI54120C (en) FRUIT PROTECTION FOR PHARMACEUTICAL FRAMEWORK ANVAIDBARA ANTIDEPRESSIVT VERKANDE TETRAHYDROPYRIMIDO (1,2-A) INDOL-TETRAHYDRO-1,3-DIAZEPINO (1-2-A) INDOL-OCH DIHYDROIMIDASO
FI54310B (en) FRUIT PROCEDURE FOR FRAMSTAELLNING AV NYA SAOSOM LAEKEMEDEL ANVAENDBARA 6-PHENYL-4H-S-TRIAZOLO (1,5-A) (1,4) BENZODIAZEPINE-2-CARBOXAMIDER
FI55660B (en) FRUIT PROTECTION FOR THERAPEUTIC USE OF THERAPEUTIC PYRAZOLO (3,4-B) PYRIDINDERIVAT
CA940134A (en) Imidazo (1,2-a) benzimidazole derivatives and process for the preparation thereof
SE399709B (en) METHOD OF PREPARING PYRIMIDO (1,2-A) (1,4) BENSODIAZEPINES
CA970373A (en) Pyrazolo (3,4-b) pyridine-5-carboxamides
SE398122B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PYRAZINO / 1,2-A / INDOL-2-CARBOXAMIDINES
IL38215A0 (en) Pyrazolopyrimidines,their preparation and pharmaceutical compositions containing them
IL44470A0 (en) Novel imidazo (1,2-a)s-triazines,their preparation and pharmaceutical compositions containing them
SE405249B (en) PROCEDURE FOR PREPARING IMIDAZO (2,1-A) ISOINDOLES
AU4579072A (en) Pyrimidopyrimidine derivatives
CA973821A (en) Aerial platform
AU464547B2 (en) Platform structure
CA925510A (en) (pyrazolo(3,4-b)pyridin-5-yl-formamidoethyl) phenylsulfonylureas
CA888729A (en) 4h-pyrido (1,2-a)pyrimidin-4-ones
SE385894B (en) PROCEDURE FOR PREPARING PYRAZOLO (1,2-B) PHTHALAZINDIONES
SE398752B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF 8-PHENYL-PYRIMIDO / 1,2-A // 1,5 / BENZODIAZOCINE DERIVATIVES